SVLSF Iv, LLC is 10% Owner at KalVista Pharmaceuticals, Inc. (KALV). They have made 7 open-market trades across 4 companies since 2014, most recently 2019-03-18.
CIK 0001422339
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $11.6M since 2014, against 5 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 100% | 60% |
| Avg Move | -7.2% | -5.7% | +11.4% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KALV | SELL | 2019-03-18 | 2019-03-20 | $26.70 | $14.0M | +3.0% | -2.4% | -24.5% |
| KALV | SELL | 2019-01-03 | 2019-01-07 | $20.31 | $139K | -10.5% | -8.5% | +44.6% |
| KALV | SELL | 2018-12-28 | 2019-01-02 | $20.01 | $660K | +1.0% | -9.3% | +45.2% |
| ENTL | BUY | 2015-02-03 | 2015-02-04 | $17.00 | $5.4M | -6.0% | +3.4% | +3.4% |
| OCUL | BUY | 2014-07-30 | 2014-07-31 | $13.00 | $6.2M | -35.9% | -1.7% | -1.7% |
| OPHT | SELL | 2014-05-29 | 2014-06-02 | $40.99 | $25.5M | -14.7% | -4.1% | -4.1% |
| OPHT | SELL | 2014-05-22 | 2014-05-27 | $38.10 | $8.4M | -14.7% | -4.1% | -4.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.